Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Technically Speaking
|
August 2012
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
TECHNICALLY SPEAKING
CDC Recommendations for Use of Tdap Are Now Simpler! Everyone Age 11 and Older Needs a Dose
Published August 2012
With pertussis widely circulating throughout the nation and infant hospitalizations and deaths escalating, the Centers for Disease Control and Prevention (CDC) has further expanded its recommendations for the use of Tdap vaccine. In June CDC published its latest Tdap recommendations, which added adults age 65 years and older to the list of people who should be vaccinated against pertussis. This means that every person in the U.S. age 11 years and older now is recommended to receive a one-time dose of Tdap vaccine the next time they see their healthcare provider (i.e., not waiting 10 years or until their next Td is due). Furthermore, CDC advises administering Tdap regardless of the interval since the person last received Td.
As seen in the timeline below, CDC has gradually expanded Tdap recommendations so that they now cover every adolescent and adult in the U.S.
March 2006— All adolescents 11–19 should receive a routine dose of Tdap (instead of Td).
December 2006
Adults 19–64 in need of a Td booster should receive a one-time Tdap dose instead of Td.
Adults in close contact with an infant should be vaccinated with Tdap regardless of the interval since their last Td dose.
Adults who need wound prophylaxis for tetanus should receive Tdap instead of Td if they have not already received a dose of Tdap.
Healthcare personnel who have direct patient contact should receive a single dose of Tdap as soon as feasible.
May 2008 — Pregnant women should receive Tdap immediately post-partum if they did not receive it prior to pregnancy.
January 2011
Adults age 65 years and older who have or anticipate having close contact with an infant younger than age 12 months should receive a dose of Tdap.
Undervaccinated children age 7 through 10 years should receive a dose of Tdap as part of their catch-up schedule.
Tdap should be administered to patients regardless of interval since they last received a dose of Td vaccine.
October 2011 — Pregnant women who have not already received a Tdap dose should receive one during pregnancy, preferably during the third or late second trimester (after 20 weeks' gestation).
June 2012 — All adults age 19 years and older, including those age 65 and older, who have not yet received a dose of Tdap, should receive a single dose now.
The recommendations have been challenging to stay up to date with, but now they’ve evolved into something quite simple to follow.
CDC recommends a single Tdap dose for all people age 11 years and older who have not previously received it. This includes pregnant women who are at 20 weeks or more gestation, as well as adults age 65 years and older.
Here are a few additional recommendations from CDC:
1.
People who anticipate being in contact with an infant should be vaccinated at least 2 weeks ahead of time.
2. Providers may administer either of the Tdap vaccines they have available in their offices. When feasible, Boostrix® (GSK) should be used for adults age 65 years and older because it is licensed for this age group; however, CDC says either Tdap product (Adacel® [sanofi], or Boostrix) may be used; both are immunogenic and would provide protection. A dose of either should be considered valid.
3. Currently, only one dose of Tdap is recommended. Thereafter, resume giving a Td booster every 10 years.
3. If you cannot verify whether a patient has ever received a dose of Tdap, CDC recommends administering a dose of Tdap.
2012 ISSUES >> view all
DECEMBER 2012
A New Program for Reporting Vaccine Errors
NOVEMBER 2012
CDC Publishes FAQs about New Vaccine Storage and Handling Guidelines
OCTOBER 2012
New Recommendations for the Use of Pneumococcal Vaccines in Adults with Certain Health Conditions
SEPTEMBER 2012
One Dose or Two? How Many Doses of Influenza Vaccine Do Children Need in the 2012-13 Season?
AUGUST 2012
CDC Recommendations for Use of Tdap Are Now Simpler! Everyone Age 11 and Older Needs a Dose
JULY 2012
Recording Vaccinations What is Required by Federal Law?
JUNE 2012
Responding to Requests for Personal Belief Exemptions Some Helpful Resources
MAY 2012
Try These Free Email Services to Stay Up to Date on Immunization Information
APRIL 2012
Guidance for Preventing Fainting and Associated Injuries after Vaccination
MARCH 2012
Minimum Ages and Minimum Intervals Between Doses of Vaccines in a Series – Why Does It Matter?
FEBRUARY 2012
Visit EZIZ.org for Practical Tools on Vaccine Administration, Storage and Handling
 
This page was reviewed on August 28, 2012
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.